Background: The role of hormonal contraception on acquisition of gonorrhea has not been well-characterized, as the transmission dynamics of Neisseria gonorrhoeae are poorly understood. The purpose of ...
Box 1. Classification of antibiotics in current use, proposed for use or else discontinued for use in the treatment of gonorrhea. I. Antibiotics currently generally recommended for the treatment of ...
Researchers have identified a protein that powers the virulence of the bacteria that causes gonorrhea, opening the possibility of a new target for antibiotics and, even better, a vaccine. Researchers ...
Cynthia Nau Cornelissen, a Distinguished University Professor and associate director of the Institute for Biomedical Sciences ...
The bacterium that causes gonorrhea infects the female reproductive tract by breaking connections between cells in the tract's protective lining, according to new research published in PLOS Pathogens.
Kartik K. Venkatesh, Ariane van der Straten, Kenneth H. Mayer, Kelly Blanchard, Gita Ramjee, Mark N. Lurie, Tsungai Chipato, Nancy S. Padian, Guy de Bruyn Sexually ...
A team of researchers may have found a way to block gonorrhea infection by blocking bacterial pathogen from using zinc, an essential mineral found in many food sources. The researchers from Georgia ...
First participant dosed with Debiopharm’s Debio 1453, a new drug candidate to address the high unmet need of multidrug-resistant infections with Neisseria gonorrhoeae LAUSANNE, Switzerland, August 26, ...
Researchers with the Hawaii Department of Health identified a cluster of Neisseria gonorrhoeae infections that displayed a decreased susceptibility to the double-antibiotic combination used to ...
LAUSANNE, Switzerland & BOSTON--(BUSINESS WIRE)--Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company, is proud to announce the extension of funding from the Combating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results